Bronchodilators: Classes, Mechanisms, and Nursing Considerations

Bronchodilators are a cornerstone of asthma and COPD therapy. This note summarizes the major drug classes, how they work, how they are used per GINA and GOLD guidelines, and the safety and monitoring points most likely to appear on the NCLEX.

Bronchodilator Classes

• SABA (Short-Acting Beta Agonist) — e.g., albuterol, salbutamol. Exam clue: first-line rescue inhaler.
• LABA (Long-Acting Beta Agonist) — e.g., salmeterol, formoterol. Exam clue: maintenance therapy (never monotherapy in asthma).
• Anticholinergics — e.g., ipratropium (short-acting), tiotropium (long-acting/LAMA). Exam clue: first-line bronchodilator in COPD.

Mechanism of Action

Beta-2 Agonists

• Stimulate β2-adrenergic receptors in bronchial smooth muscle → airway relaxation and improved airflow.
• SABAs produce rapid bronchodilation within minutes — used for acute asthma symptoms.
• LABAs provide prolonged bronchodilation lasting ~12 hours or longer — used for maintenance therapy.

Anticholinergics

• Block muscarinic receptors in the airways, reducing vagal-mediated bronchoconstriction and decreasing mucus secretion.
• Particularly effective in COPD management.

Indications & Guidelines

Bronchodilators are used for:

• Asthma
• Chronic obstructive pulmonary disease (COPD)
• Acute bronchospasm

GINA (Asthma) Guidelines

• SABAs such as albuterol are used for rapid relief of acute symptoms.
• LABAs must NOT be used as monotherapy in asthma.
• LABAs should always be combined with inhaled corticosteroids (ICS).

GOLD (COPD) Guidelines

• Long-acting bronchodilators (LABA or LAMA) are first-line maintenance therapy.
• Short-acting bronchodilators may be used for symptom relief during exacerbations.

Side Effects

• Beta-2 agonists: tachycardia, tremors, palpitations, nervousness.
• Anticholinergics: dry mouth, throat irritation, and urinary retention in susceptible patients.

Labs and Monitoring

Monitor patients on bronchodilators for:

• Heart rate
• Respiratory status
• Frequency of rescue inhaler use

Key points:

• Frequent SABA use may indicate poor asthma control and need for therapy adjustment.
• Peak expiratory flow (PEF) monitoring helps evaluate treatment response.

Contraindications and Cautions

Use cautiously in patients with:

• Cardiac arrhythmias
• Severe hypertension
• Hyperthyroidism

Additional cautions:

• Beta agonists can worsen tachycardia or arrhythmias.
• Anticholinergic inhalers should be used cautiously in patients with glaucoma or urinary retention.

Pregnancy Safety

• Inhaled bronchodilators are generally considered safe in pregnancy when needed for asthma control.
• Maintaining maternal oxygenation is essential for fetal health.
• Albuterol is commonly used for acute symptom relief in pregnant patients with asthma.

Nursing Safety Rules & High-Yield NCLEX Notes

• Use SABA inhalers for acute asthma attacks.
• LABAs should never be used alone in asthma therapy.
• When using multiple inhalers, give the bronchodilator first, followed by the inhaled corticosteroid.

NCLEX high-yield points:

• Albuterol is the most commonly tested rescue bronchodilator.
• LABA monotherapy increases asthma-related mortality risk.
• Frequent SABA use suggests uncontrolled asthma.

Key Takeaways

• Bronchodilators relax airway smooth muscle and improve airflow in asthma and COPD.
• SABAs (albuterol) are first-line rescue therapy; LABAs are for maintenance and must be combined with ICS in asthma.
• Anticholinergics (ipratropium, tiotropium) are key bronchodilators in COPD management.
• Watch for tachycardia and tremors with beta agonists; dry mouth and urinary retention with anticholinergics.
• Frequent SABA use = poorly controlled asthma — reassess therapy.
• Always give the bronchodilator before the corticosteroid when multiple inhalers are prescribed.